Pitcairn’s AMAG Pharmaceuticals AMAG Stock Holding History

Pitcairn’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,327	Closed	-$230K	–	481
2015 Q2	$230K	Buy	+3,327	New	+$209K	0.03%	417

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pitcairn's AMAG Position: Q3 2015 in Review

Pitcairn sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 3,327 shares — an estimated $230K sold.

Pitcairn first reported a position in AMAG in Q2 2015 and held it in 1 quarter. The position peaked at $230K in Q2 2015. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

Pitcairn reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Pitcairn sold 3,327 AMAG Pharmaceuticals shares in Q3 2015, an estimated $230K.
Pitcairn first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 1 quarter.
Pitcairn's AMAG Pharmaceuticals position peaked at $230K in Q2 2015.
210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on Pitcairn's 13F filing for Q3 2015, filed 2 Nov 2015.